HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate’s Tom’s Of Maine Back In Federal Court Over ‘Natural’ Claims

Executive Summary

Tom's natural claims on toothpastes and deodorants are false and misleading, a plaintiff alleges in a proposed class action filed in Massachusetts federal court. Similar to previous complaints against Colgate/Tom’s, the plaintiff’s case is premised on the contention that “natural,” as opposed to “100% natural,” means no synthetic ingredients.

You may also be interested in...



US House Bill Would Define ‘Natural’ Cosmetic, Provide FDA Enforcement Authority

Beautycounter is among industry supporters of the Natural Cosmetic Act, introduced in the House on 5 October as the solution to greenwashing in the US personal-care sector.

Are ‘Natural’ Claims Equivalent To ‘All Natural’? Tarte’s $1.7m Settlement Offers Little Instruction

Tarte admits no wrongdoing in its settlement with nationwide purchasers of its “high performance naturals,” and it put up little fight in order to minimize costs. Insight remains limited as to whether federal courts agree with plaintiffs that general “natural” claims on cosmetic products – as opposed to “all natural” or “100% natural” assertions – mean no synthetic ingredients at all.

Delaying 'Natural' Personal Care Claims Litigation Until FDA Acts Comes Naturally – Colgate

Colgate asks federal courts in New York and California to stay class action litigation over “natural” claims for Tom’s of Maine until FDA rulemaking or guidance. Colgate says the cases are ripe for application of “primary jurisdiction doctrine” giving deference to FDA.

Related Content

Topics

UsernamePublicRestriction

Register

RS149609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel